跳至主要内容
临床试验/PER-034-02
PER-034-02已完成未知

4-MONTH MONITORING STUDY TO EVALUATE THE RATE OF NASAL POLYPOSIS IN SUBJECTS WHICH IMPROVED WITH UP TO 4 MONTHS OF TREATMENT WITH MOMETHASONE FUROATE IN NASAL OR PLACEBO AEROSOL IN STUDY P01925

SCHERING PLOUGH RESEARCH INSTITUTE,0 个研究点目标入组 0 人开始时间: 2002年5月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The subjects must present an improvement with the treatment of the Study PCI 925 and be able to join immediately.
  • The subjects must not have experienced an important change in their clinical history or in the concomitant medication used, which could make the evaluations of this study impossible.

排除标准

  • Women who intend to become pregnant or who are pregnant
  • find breastfeeding, or are not using a medically acceptable contraceptive.
  • Subjects who use concomitant medications that motivate their exclusion.

研究者

相似试验